60 Degrees Pharmaceuticals, Inc. (SXTP) stock
SXTPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTPW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3060% below fair value
$0.52−0.00 (-0.19%)
Close on Nov 13, 2026Market cap $1.82MP/E –Yield –
60 Degrees Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
60 Degrees Pharmaceuticals's enterprise value was $276.47K on Nov 11, 2026, against $161.29K a year earlier. Over the last 3 years it ranged from -$3.73M to $27.38M, with a median of -$37.58K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $276.47K | – |
| 2025 | Dec 31, 2025 | -$2.10M | – |
| 2024 | Dec 31, 2024 | -$2.68M | -391.9% |
| 2023 | Dec 29, 2023 | $917.56K | – |
See a number that looks wrong?